Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Non-Current Assets: 2009-2021

Historic Non-Current Assets for Avadel Pharmaceuticals (AVDL) over the last 13 years, with Dec 2021 value amounting to $54.8 million.

  • Avadel Pharmaceuticals' Non-Current Assets fell 44.16% to $32.5 million in Q3 2022 from the same period last year, while for Sep 2022 it was $32.5 million, marking a year-over-year decrease of 44.16%. This contributed to the annual value of $54.8 million for FY2021, which is 13.68% up from last year.
  • Avadel Pharmaceuticals' Non-Current Assets amounted to $54.8 million in FY2021, which was up 13.68% from $48.2 million recorded in FY2020.
  • In the past 5 years, Avadel Pharmaceuticals' Non-Current Assets registered a high of $129.3 million during FY2017, and its lowest value of $48.2 million during FY2020.
  • Over the past 3 years, Avadel Pharmaceuticals' median Non-Current Assets value was $54.8 million (recorded in 2021), while the average stood at $57.3 million.
  • As far as peak fluctuations go, Avadel Pharmaceuticals' Non-Current Assets soared by 101.10% in 2017, and later crashed by 49.38% in 2018.
  • Avadel Pharmaceuticals' Non-Current Assets (Yearly) stood at $129.3 million in 2017, then crashed by 49.38% to $65.4 million in 2018, then increased by 5.51% to $69.1 million in 2019, then crashed by 30.23% to $48.2 million in 2020, then rose by 13.68% to $54.8 million in 2021.